{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T15:14:01Z","timestamp":1786720441759,"version":"build-2736575974"},"reference-count":104,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":65,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372590"],"award-info":[{"award-number":["82372590"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["U1601224"],"award-info":[{"award-number":["U1601224"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["82172930"],"award-info":[{"award-number":["82172930"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Noncommunicable Chronic Diseases-National Science and Technology Major Project","award":["2023ZD0501101"],"award-info":[{"award-number":["2023ZD0501101"]}]},{"name":"Science and Technology Innovation Key R&D Program of Chongqing","award":["CSTB2024TIAD-STX0006"],"award-info":[{"award-number":["CSTB2024TIAD-STX0006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genome Med"],"DOI":"10.1186\/s13073-026-01684-0","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:38:37Z","timestamp":1781073517000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Geospatial genetic evolution and phenotypic plasticity in triple-negative breast cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Ruoxi","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyue","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shichen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaping","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cuijuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanlan","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qimin","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guibo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shusen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"issue":"3","key":"1684_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 2(Suppl 2","key":"1684_CR2","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.3816\/CBC.2009.s.008","volume":"9","author":"CK Anders","year":"2009","unstructured":"Anders CK, Carey LA. Biology, metastatic patterns, and treatment of patients with triple-negative breast cancer. Clin Breast Cancer. 2009;9(Suppl 2(Suppl 2)):S73-81.","journal-title":"Clin Breast Cancer"},{"issue":"4","key":"1684_CR3","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1002\/cncr.23243","volume":"112","author":"M Brown","year":"2008","unstructured":"Brown M, Tsodikov A, Bauer KR, Parise CA, Caggiano V. The role of human epidermal growth factor receptor 2 in the survival of women with estrogen and progesterone receptor-negative, invasive breast cancer: the California Cancer Registry, 1999\u20132004. Cancer. 2008;112(4):737\u201347.","journal-title":"Cancer"},{"issue":"2","key":"1684_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1158\/2159-8290.CD-18-1177","volume":"9","author":"AC Garrido-Castro","year":"2019","unstructured":"Garrido-Castro AC, Lin NU, Polyak K. Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment. Cancer Discov. 2019;9(2):176\u201398.","journal-title":"Cancer Discov"},{"issue":"7","key":"1684_CR5","doi-asserted-by":"publisher","first-page":"2750","DOI":"10.1172\/JCI45014","volume":"121","author":"BD Lehmann","year":"2011","unstructured":"Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750\u201367.","journal-title":"J Clin Invest"},{"issue":"6","key":"1684_CR6","doi-asserted-by":"publisher","first-page":"e0157368","DOI":"10.1371\/journal.pone.0157368","volume":"11","author":"BD Lehmann","year":"2016","unstructured":"Lehmann BD, Jovanovi\u0107 B, Chen X, Estrada MV, Johnson KN, Shyr Y, et al. Refinement of Triple-Negative Breast Cancer Molecular Subtypes: Implications for Neoadjuvant Chemotherapy Selection. PLoS ONE. 2016;11(6):e0157368.","journal-title":"PLoS ONE"},{"issue":"4","key":"1684_CR7","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1093\/annonc\/mdy024","volume":"29","author":"Y Bareche","year":"2018","unstructured":"Bareche Y, Venet D, Ignatiadis M, Aftimos P, Piccart M, Rothe F, et al. Unravelling triple-negative breast cancer molecular heterogeneity using an integrative multiomic analysis. Ann Oncol. 2018;29(4):895\u2013902.","journal-title":"Ann Oncol"},{"issue":"7","key":"1684_CR8","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1158\/1078-0432.CCR-14-0432","volume":"21","author":"MD Burstein","year":"2015","unstructured":"Burstein MD, Tsimelzon A, Poage GM, Covington KR, Contreras A, Fuqua SA, et al. Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer. Clin Cancer Res. 2015;21(7):1688\u201398.","journal-title":"Clin Cancer Res"},{"issue":"1","key":"1684_CR9","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s13058-019-1148-6","volume":"21","author":"P J\u00e9z\u00e9quel","year":"2019","unstructured":"J\u00e9z\u00e9quel P, Kerdraon O, Hondermarck H, Gu\u00e9rin-Charbonnel C, Lasla H, Gouraud W, et al. Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications. Breast Cancer Res. 2019;21(1):65.","journal-title":"Breast Cancer Res"},{"issue":"10","key":"1684_CR10","doi-asserted-by":"publisher","first-page":"3344","DOI":"10.1245\/s10434-019-07565-8","volume":"26","author":"ML DiNome","year":"2019","unstructured":"DiNome ML, Orozco JIJ, Matsuba C, Manughian-Peter AO, Ensenyat-Mendez M, Chang SC, et al. Clinicopathological features of triple-negative breast cancer epigenetic subtypes. Ann Surg Oncol. 2019;26(10):3344\u201353.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"1684_CR11","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.cmet.2020.10.012","volume":"33","author":"Y Gong","year":"2021","unstructured":"Gong Y, Ji P, Yang YS, Xie S, Yu TJ, Xiao Y, et al. Metabolic-pathway-based subtyping of triple-negative breast cancer reveals potential therapeutic targets. Cell Metab. 2021;33(1):51-64.e9.","journal-title":"Cell Metab"},{"issue":"3","key":"1684_CR12","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","volume":"35","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, Ma D, Suo C, Shi J, Xue M, Hu X, et al. Genomic and transcriptomic landscape of triple-negative breast cancers: subtypes and treatment strategies. Cancer Cell. 2019;35(3):428-440.e5.","journal-title":"Cancer Cell"},{"issue":"7","key":"1684_CR13","doi-asserted-by":"publisher","first-page":"100694","DOI":"10.1016\/j.xcrm.2022.100694","volume":"3","author":"L Jiang","year":"2022","unstructured":"Jiang L, You C, Xiao Y, Wang H, Su GH, Xia BQ, et al. Radiogenomic analysis reveals tumor heterogeneity of triple-negative breast cancer. Cell Rep Med. 2022;3(7):100694.","journal-title":"Cell Rep Med"},{"issue":"5","key":"1684_CR14","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1002\/cai2.146","volume":"3","author":"B Han","year":"2024","unstructured":"Han B, Han X, Luo H, Nasir J, Chen C, Shao Z, et al. Multiomics and single-cell sequencings reveal the specific biological characteristics of low Ki-67 triple-negative breast cancer. Cancer Innov. 2024;3(5):e146.","journal-title":"Cancer Innov"},{"issue":"7936","key":"1684_CR15","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/s41586-022-05425-2","volume":"611","author":"A Lomakin","year":"2022","unstructured":"Lomakin A, Svedlund J, Strell C, Gataric M, Shmatko A, Rukhovich G, et al. Spatial genomics maps the structure, nature and evolution of cancer clones. Nature. 2022;611(7936):594\u2013602.","journal-title":"Nature"},{"issue":"7937","key":"1684_CR16","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/s41586-022-05311-x","volume":"611","author":"J Househam","year":"2022","unstructured":"Househam J, Heide T, Cresswell GD, Spiteri I, Kimberley C, Zapata L, et al. Phenotypic plasticity and genetic control in colorectal cancer evolution. Nature. 2022;611(7937):744\u201353.","journal-title":"Nature"},{"issue":"7853","key":"1684_CR17","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41586-021-03357-x","volume":"592","author":"DC Minussi","year":"2021","unstructured":"Minussi DC, Nicholson MD, Ye H. Breast tumours maintain a reservoir of subclonal diversity during expansion. Nature. 2021;592(7853):302\u20138.","journal-title":"Nature"},{"issue":"7403","key":"1684_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin SF, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u201352.","journal-title":"Nature"},{"issue":"6","key":"1684_CR19","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.ccell.2022.05.005","volume":"40","author":"DM Wolf","year":"2022","unstructured":"Wolf DM, Yau C, Wulfkuhle J, Brown-Swigart L, Gallagher RI, Lee PRE, et al. Redefining breast cancer subtypes to guide treatment prioritization and maximize response: Predictive biomarkers across 10 cancer therapies. Cancer Cell. 2022;40(6):609-623 e6.","journal-title":"Cancer Cell"},{"issue":"4","key":"1684_CR20","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S1470-2045(18)30111-6","volume":"19","author":"S Loibl","year":"2018","unstructured":"Loibl S, O\u2019Shaughnessy J, Untch M, Sikov WM, Rugo HS, McKee MD, et al. Addition of the PARP inhibitor veliparib plus carboplatin or carboplatin alone to standard neoadjuvant chemotherapy in triple-negative breast cancer (BrighTNess): a randomised, phase 3 trial. Lancet Oncol. 2018;19(4):497\u2013509.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1684_CR21","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41523-022-00465-3","volume":"8","author":"J Staaf","year":"2022","unstructured":"Staaf J, Hakkinen J, Hegardt C, Saal LH, Kimbung S, Hedenfalk I, et al. RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer. NPJ Breast Cancer. 2022;8(1):94.","journal-title":"NPJ Breast Cancer"},{"issue":"5","key":"1684_CR22","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","volume":"27","author":"A Bassez","year":"2021","unstructured":"Bassez A, Vos H, Van Dyck L, Floris G, Arijs I, Desmedt C, et al. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nat Med. 2021;27(5):820\u201332.","journal-title":"Nat Med"},{"issue":"1","key":"1684_CR23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ccell.2023.12.012","volume":"42","author":"SL Shiao","year":"2024","unstructured":"Shiao SL, Gouin KH 3rd, Ing N, Ho A, Basho R, Shah A, et al. Single-cell and spatial profiling identify three response trajectories to pembrolizumab and radiation therapy in triple negative breast cancer. Cancer Cell. 2024;42(1):70-84 e8.","journal-title":"Cancer Cell"},{"issue":"1","key":"1684_CR24","doi-asserted-by":"publisher","first-page":"6584","DOI":"10.1038\/s41467-025-61034-3","volume":"16","author":"Q Zhu","year":"2025","unstructured":"Zhu Q, Balasubramanian A, Asirvatham JR, Chatterjee M, Piyarathna B, Kaur J, et al. Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in Black American and White American patients with TNBC. Nat Commun. 2025;16(1):6584.","journal-title":"Nat Commun"},{"issue":"10","key":"1684_CR25","doi-asserted-by":"publisher","first-page":"100404","DOI":"10.1016\/j.xcrm.2021.100404","volume":"2","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Wang W, Lin F, Jordan T, Li G, Silverman S, et al. Genome profiles of pathologist-defined cell clusters by multiregional LCM and G&T-seq in one triple-negative breast cancer patient. Cell Rep Med. 2021;2(10):100404.","journal-title":"Cell Rep Med"},{"issue":"8","key":"1684_CR26","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts D, Wauters E, Boeckx B, Aibar S, Nittner D, Burton O, et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med. 2018;24(8):1277\u201389.","journal-title":"Nat Med"},{"issue":"6","key":"1684_CR27","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1038\/nprot.2012.039","volume":"7","author":"T Baslan","year":"2012","unstructured":"Baslan T, Kendall J, Rodgers L, Cox H, Riggs M, Stepansky A, et al. Genome-wide copy number analysis of single cells. Nat Protoc. 2012;7(6):1024\u201341.","journal-title":"Nat Protoc"},{"issue":"1","key":"1684_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/gigascience\/gix120","volume":"7","author":"Y Chen","year":"2018","unstructured":"Chen Y, Chen Y, Shi C, Huang Z, Zhang Y, Li S, et al. SOAPnuke: a MapReduce acceleration-supported software for integrated quality control and preprocessing of high-throughput sequencing data. Gigascience. 2018;7(1):1\u20136.","journal-title":"Gigascience"},{"issue":"14","key":"1684_CR29","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"issue":"16","key":"1684_CR30","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment\/Map format and SAMtools. Bioinformatics. 2009;25(16):2078\u20139.","journal-title":"Bioinformatics"},{"issue":"1","key":"1684_CR31","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s13059-016-1029-6","volume":"17","author":"Y Fan","year":"2016","unstructured":"Fan Y, Xi L, Hughes DS, Zhang J, Zhang J, Futreal PA, et al. MuSE: accounting for tumor heterogeneity using a sample-specific error model improves sensitivity and specificity in mutation calling from sequencing data. Genome Biol. 2016;17(1):178.","journal-title":"Genome Biol"},{"issue":"1110","key":"1684_CR32","first-page":"11.10.1","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. 2013;43(1110):11.10.1-11.10.33.","journal-title":"Curr Protoc Bioinformatics"},{"issue":"4","key":"1684_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1101\/gr.221028.117","volume":"28","author":"JA Wala","year":"2018","unstructured":"Wala JA, Bandopadhayay P, Greenwald NF, O\u2019Rourke R, Sharpe T, Stewart C, et al. SvABA: genome-wide detection of structural variants and indels by local assembly. Genome Res. 2018;28(4):581\u201391.","journal-title":"Genome Res"},{"issue":"8","key":"1684_CR34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41592-018-0051-x","volume":"15","author":"S Kim","year":"2018","unstructured":"Kim S, Scheffler K, Halpern AL, Bekritsky MA, Noh E, K\u00e4llberg M, et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat Methods. 2018;15(8):591\u20134.","journal-title":"Nat Methods"},{"issue":"3","key":"1684_CR35","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1093\/bioinformatics\/btr665","volume":"28","author":"DE Larson","year":"2012","unstructured":"Larson DE, Harris CC, Chen K, Koboldt DC, Abbott TE, Dooling DJ, et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics. 2012;28(3):311\u20137.","journal-title":"Bioinformatics"},{"key":"1684_CR36","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s42003-018-0023-9","volume":"1","author":"G Narzisi","year":"2018","unstructured":"Narzisi G, Corvelo A, Arora K, Bergmann EA, Shah M, Musunuri R, et al. Genome-wide somatic variant calling using localized colored de Bruijn graphs. Commun Biol. 2018;1:20.","journal-title":"Commun Biol"},{"issue":"16","key":"1684_CR37","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"1684_CR38","doi-asserted-by":"publisher","first-page":"5144","DOI":"10.1038\/s41467-018-07627-7","volume":"9","author":"J Singer","year":"2018","unstructured":"Singer J, Kuipers J, Jahn K, Beerenwinkel N. Single-cell mutation identification via phylogenetic inference. Nat Commun. 2018;9(1):5144.","journal-title":"Nat Commun"},{"issue":"1","key":"1684_CR39","doi-asserted-by":"publisher","first-page":"6744","DOI":"10.1038\/s41467-021-26938-w","volume":"12","author":"D L\u00e4hnemann","year":"2021","unstructured":"L\u00e4hnemann D, K\u00f6ster J, Fischer U, Borkhardt A, McHardy AC, Sch\u00f6nhuth A. Accurate and scalable variant calling from single cell DNA sequencing data with ProSolo. Nat Commun. 2021;12(1):6744.","journal-title":"Nat Commun"},{"issue":"5","key":"1684_CR40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nmeth.4227","volume":"14","author":"X Dong","year":"2017","unstructured":"Dong X, Zhang L, Milholland B, Lee M, Maslov AY, Wang T, et al. Accurate identification of single-nucleotide variants in whole-genome-amplified single cells. Nat Methods. 2017;14(5):491\u20133.","journal-title":"Nat Methods"},{"key":"1684_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13059-016-0893-4","volume":"17","author":"R Rosenthal","year":"2016","unstructured":"Rosenthal R, McGranahan N, Herrero J, Taylor BS, Swanton C. DeconstructSigs: delineating mutational processes in single tumors distinguishes DNA repair deficiencies and patterns of carcinoma evolution. Genome Biol. 2016;17:31.","journal-title":"Genome Biol"},{"issue":"4","key":"1684_CR42","doi-asserted-by":"publisher","first-page":"R41","DOI":"10.1186\/gb-2011-12-4-r41","volume":"12","author":"CH Mermel","year":"2011","unstructured":"Mermel CH, Schumacher SE, Hill B, Meyerson ML, Beroukhim R, Getz G. GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers. Genome Biol. 2011;12(4):R41.","journal-title":"Genome Biol"},{"key":"1684_CR43","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1186\/1471-2105-12-323","volume":"12","author":"B Li","year":"2011","unstructured":"Li B, Dewey CN. RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome. BMC Bioinformatics. 2011;12:323.","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"1684_CR44","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"11","key":"1684_CR45","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1038\/nbt.3344","volume":"33","author":"SA Shukla","year":"2015","unstructured":"Shukla SA, Rooney MS, Rajasagi M, Tiao G, Dixon PM, Lawrence MS, et al. Comprehensive analysis of cancer-associated somatic mutations in class I HLA genes. Nat Biotechnol. 2015;33(11):1152\u20138.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1684_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cels.2020.06.010","volume":"11","author":"TJ O'Donnell","year":"2020","unstructured":"O\u2019Donnell TJ, Rubinsteyn A, Laserson U. MHCflurry 2.0: improved pan-allele prediction of MHC class I-presented peptides by incorporating antigen processing. Cell Syst. 2020;11(1):42-48.e7.","journal-title":"Cell Syst"},{"issue":"5","key":"1684_CR47","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1038\/s41592-023-01891-2","volume":"20","author":"M Mukhopadhyay","year":"2023","unstructured":"Mukhopadhyay M. Machine learning for MHC II specificities. Nat Methods. 2023;20(5):632.","journal-title":"Nat Methods"},{"issue":"4","key":"1684_CR48","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/bioinformatics\/btv639","volume":"32","author":"M Andreatta","year":"2016","unstructured":"Andreatta M, Nielsen M. Gapped sequence alignment using artificial neural networks: application to the MHC class I system. Bioinformatics. 2016;32(4):511\u20137.","journal-title":"Bioinformatics"},{"issue":"9","key":"1684_CR49","doi-asserted-by":"publisher","first-page":"3360","DOI":"10.4049\/jimmunol.1700893","volume":"199","author":"V Jurtz","year":"2017","unstructured":"Jurtz V, Paul S, Andreatta M, Marcatili P, Peters B, Nielsen M. NetMHCpan-4.0: improved peptide-MHC class I interaction predictions integrating eluted ligand and peptide binding affinity data. J Immunol. 2017;199(9):3360\u20138.","journal-title":"J Immunol"},{"issue":"3","key":"1684_CR50","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation. 2021;2(3):100141.","journal-title":"Innovation"},{"key":"1684_CR51","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"3","key":"1684_CR52","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nmeth.3254","volume":"12","author":"Y Hart","year":"2015","unstructured":"Hart Y, Sheftel H, Hausser J, Szekely P, Ben-Moshe NB, Korem Y, et al. Inferring biological tasks using Pareto analysis of high-dimensional data. Nat Methods. 2015;12(3):233\u20135, 3 p following 235.","journal-title":"Nat Methods"},{"issue":"8","key":"1684_CR53","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ng.3593","volume":"48","author":"MJ Alvarez","year":"2016","unstructured":"Alvarez MJ, Shen Y, Giorgi FM, Lachmann A, Ding BB, Ye BH, et al. Functional characterization of somatic mutations in cancer using network-based inference of protein activity. Nat Genet. 2016;48(8):838\u201347.","journal-title":"Nat Genet"},{"issue":"3","key":"1684_CR54","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1572-0241.1998.00394.x","volume":"93","author":"HH Xia","year":"1998","unstructured":"Xia HH, Talley NJ. Helicobacter pylori infection, reflux esophagitis, and atrophic gastritis: an unexplored triangle. Am J Gastroenterol. 1998;93(3):394\u2013400.","journal-title":"Am J Gastroenterol"},{"issue":"4","key":"1684_CR55","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nmeth.2883","volume":"11","author":"A Roth","year":"2014","unstructured":"Roth A, Khattra J, Yap D, Wan A, Laks E, Biele J, et al. PyClone: statistical inference of clonal population structure in cancer. Nat Methods. 2014;11(4):396\u20138.","journal-title":"Nat Methods"},{"issue":"7","key":"1684_CR56","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41588-020-0628-z","volume":"52","author":"Z Hu","year":"2020","unstructured":"Hu Z, Li Z, Ma Z, Curtis C. Multi-cancer analysis of clonality and the timing of systemic spread in paired primary tumors and metastases. Nat Genet. 2020;52(7):701\u20138.","journal-title":"Nat Genet"},{"issue":"3","key":"1684_CR57","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.cell.2018.03.057","volume":"173","author":"S Turajlic","year":"2018","unstructured":"Turajlic S, Xu H, Litchfield K, Rowan A, Chambers T, Lopez JI, et al. Tracking Cancer Evolution Reveals Constrained Routes to Metastases: TRACERx Renal. Cell. 2018;173(3):581-594.e12.","journal-title":"Cell"},{"issue":"6574","key":"1684_CR58","doi-asserted-by":"publisher","first-page":"abe6474","DOI":"10.1126\/science.abe6474","volume":"374","author":"L Zheng","year":"2021","unstructured":"Zheng L, Qin S, Si W, Wang A, Xing B, Gao R, et al. Pan-cancer single-cell landscape of tumor-infiltrating T cells. Science. 2021;374(6574):abe6474.","journal-title":"Science"},{"key":"1684_CR59","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612.","journal-title":"Nat Commun"},{"issue":"1","key":"1684_CR60","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s13059-017-1349-1","volume":"18","author":"D Aran","year":"2017","unstructured":"Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220.","journal-title":"Genome Biol"},{"issue":"1","key":"1684_CR61","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13059-016-1070-5","volume":"17","author":"E Becht","year":"2016","unstructured":"Becht E, Giraldo NA, Lacroix L, Buttard B, Elarouci N, Petitprez F, et al. Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016;17(1):218.","journal-title":"Genome Biol"},{"issue":"10","key":"1684_CR62","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang P, Gu S, Pan D, Fu J, Sahu A, Hu X, et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat Med. 2018;24(10):1550\u20138.","journal-title":"Nat Med"},{"issue":"43","key":"1684_CR63","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"10","key":"1684_CR64","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1038\/s41591-019-0582-4","volume":"25","author":"J Staaf","year":"2019","unstructured":"Staaf J, Glodzik D. Whole-genome sequencing of triple-negative breast cancers in a population-based clinical study. Nat Med. 2019;25(10):1526\u201333.","journal-title":"Nat Med"},{"issue":"3","key":"1684_CR65","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.ccell.2018.08.008","volume":"34","author":"P Razavi","year":"2018","unstructured":"Razavi P, Chang MT, Xu G, Bandlamudi C, Ross DS, Vasan N, et al. The genomic landscape of endocrine-resistant advanced breast cancers. Cancer Cell. 2018;34(3):427-438.e6.","journal-title":"Cancer Cell"},{"issue":"4","key":"1684_CR66","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.7150\/thno.81847","volume":"13","author":"C Marvalim","year":"2023","unstructured":"Marvalim C, Datta A, Lee SC. Role of p53 in breast cancer progression: an insight into p53 targeted therapy. Theranostics. 2023;13(4):1421\u201342.","journal-title":"Theranostics"},{"issue":"4","key":"1684_CR67","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ccell.2024.03.006","volume":"42","author":"CJ Lin","year":"2024","unstructured":"Lin CJ, Jin X, Ma D, Chen C, Ou-Yang Y, Pei YC, et al. Genetic interactions reveal distinct biological and therapeutic implications in breast cancer. Cancer Cell. 2024;42(4):701-719.e12.","journal-title":"Cancer Cell"},{"issue":"2","key":"1684_CR68","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1158\/2159-8290.CD-23-0704","volume":"14","author":"A Varkaris","year":"2024","unstructured":"Varkaris A, Fece de la Cruz F, Martin EE, Norden BL, Chevalier N, Kehlmann AM, et al. Allosteric PI3K\u03b1 inhibition overcomes on-target resistance to orthosteric inhibitors mediated by secondary PIK3CA mutations. Cancer Discov. 2024;14(2):227\u201339.","journal-title":"Cancer Discov"},{"issue":"17","key":"1684_CR69","doi-asserted-by":"publisher","first-page":"3868","DOI":"10.1158\/1078-0432.CCR-24-0459","volume":"30","author":"P Jank","year":"2024","unstructured":"Jank P, Karn T, van Mackelenbergh M, Lindner J, Treue D, Huober J, et al. An analysis of PIK3CA hotspot mutations and response to neoadjuvant therapy in patients with breast cancer from four prospective clinical trials. Clin Cancer Res. 2024;30(17):3868\u201380.","journal-title":"Clin Cancer Res"},{"issue":"7793","key":"1684_CR70","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","volume":"578","author":"LB Alexandrov","year":"2020","unstructured":"Alexandrov LB, Kim J, Haradhvala NJ, Huang MN, Tian Ng AW, Wu Y, et al. The repertoire of mutational signatures in human cancer. Nature. 2020;578(7793):94\u2013101.","journal-title":"Nature"},{"issue":"7964","key":"1684_CR71","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41586-023-06054-z","volume":"618","author":"F Mart\u00ednez-Jim\u00e9nez","year":"2023","unstructured":"Mart\u00ednez-Jim\u00e9nez F, Movasati A, Brunner SR, Nguyen L, Priestley P, Cuppen E, et al. Pan-cancer whole-genome comparison of primary and metastatic solid tumours. Nature. 2023;618(7964):333\u201341.","journal-title":"Nature"},{"issue":"1","key":"1684_CR72","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/s41422-023-00909-w","volume":"34","author":"LP Ge","year":"2024","unstructured":"Ge LP, Jin X, Ma D, Wang ZY, Liu CL, Zhou CZ, et al. ZNF689 deficiency promotes intratumor heterogeneity and immunotherapy resistance in triple-negative breast cancer. Cell Res. 2024;34(1):58\u201375.","journal-title":"Cell Res"},{"issue":"7403","key":"1684_CR73","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/nature10933","volume":"486","author":"SP Shah","year":"2012","unstructured":"Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486(7403):395\u20139.","journal-title":"Nature"},{"issue":"1","key":"1684_CR74","doi-asserted-by":"publisher","first-page":"6276","DOI":"10.1038\/s41467-021-26502-6","volume":"12","author":"BD Lehmann","year":"2021","unstructured":"Lehmann BD, Colaprico A, Silva TC, Chen J, An H, Ban Y, et al. Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes. Nat Commun. 2021;12(1):6276.","journal-title":"Nat Commun"},{"issue":"21","key":"1684_CR75","doi-asserted-by":"publisher","first-page":"5572","DOI":"10.1158\/0008-5472.CAN-20-3242","volume":"81","author":"KW Evans","year":"2021","unstructured":"Evans KW, Yuca E, Scott SS, Zhao M, Paez Arango N, Cruz Pico CX, et al. Oxidative phosphorylation is a metabolic vulnerability in chemotherapy-resistant triple-negative breast cancer. Cancer Res. 2021;81(21):5572\u201381.","journal-title":"Cancer Res"},{"issue":"6","key":"1684_CR76","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0734-9750(00)00045-8","volume":"18","author":"P Ravindra","year":"2000","unstructured":"Anupama, Ravindra P. Value-added food: single cell protein. Biotechnol Adv. 2000;18(6):459\u201379.","journal-title":"Biotechnol Adv"},{"issue":"11","key":"1684_CR77","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1038\/s43018-024-00773-6","volume":"5","author":"MD Iglesia","year":"2024","unstructured":"Iglesia MD, Jayasinghe RG, Chen S, Terekhanova NV, Herndon JM, Storrs E, et al. Differential chromatin accessibility and transcriptional dynamics define breast cancer subtypes and their lineages. Nat Cancer. 2024;5(11):1713\u201336.","journal-title":"Nat Cancer"},{"issue":"Pt 1","key":"1684_CR78","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.semcancer.2019.03.004","volume":"67","author":"D Grimm","year":"2020","unstructured":"Grimm D, Bauer J, Wise P, Kr\u00fcger M, Simonsen U, Wehland M, et al. The role of SOX family members in solid tumours and metastasis. Semin Cancer Biol. 2020;67(Pt 1):122\u201353.","journal-title":"Semin Cancer Biol"},{"issue":"1","key":"1684_CR79","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.ccell.2020.12.001","volume":"39","author":"A Bagati","year":"2021","unstructured":"Bagati A, Kumar S, Jiang P, Pyrdol J, Zou AE, Godicelj A, et al. Integrin \u03b1v\u03b26-TGF\u03b2-SOX4 pathway drives immune evasion in triple-negative breast cancer. Cancer Cell. 2021;39(1):54-67.e9.","journal-title":"Cancer Cell"},{"issue":"7685","key":"1684_CR80","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/nature25023","volume":"552","author":"H Yang","year":"2017","unstructured":"Yang H, Jiang X, Li B, Yang HJ, Miller M, Yang A, et al. Mechanisms of mTORC1 activation by RHEB and inhibition by PRAS40. Nature. 2017;552(7685):368\u201373.","journal-title":"Nature"},{"issue":"3","key":"1684_CR81","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1158\/0008-5472.CAN-22-2709","volume":"83","author":"L Liao","year":"2023","unstructured":"Liao L, Zhang YL. Protein phosphatase 1 subunit PPP1R14B stabilizes STMN1 to promote progression and paclitaxel resistance in triple-negative breast cancer. Cancer Res. 2023;83(3):471\u201384.","journal-title":"Cancer Res"},{"issue":"1","key":"1684_CR82","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1006\/dbio.2001.0410","volume":"238","author":"MT Lewis","year":"2001","unstructured":"Lewis MT, Ross S, Strickland PA, Sugnet CW, Jimenez E, Hui C, et al. The Gli2 transcription factor is required for normal mouse mammary gland development. Dev Biol. 2001;238(1):133\u201344.","journal-title":"Dev Biol"},{"issue":"394","key":"1684_CR83","doi-asserted-by":"publisher","first-page":"ra92","DOI":"10.1126\/scisignal.aaa7355","volume":"8","author":"H Villanueva","year":"2015","unstructured":"Villanueva H, Visbal AP, Obeid NF, Ta AQ, Faruki AA, Wu MF, et al. An essential role for G\u03b1(i2) in Smoothened-stimulated epithelial cell proliferation in the mammary gland. Sci Signal. 2015;8(394):ra92.","journal-title":"Sci Signal"},{"issue":"7341","key":"1684_CR84","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1038\/nature09807","volume":"472","author":"N Navin","year":"2011","unstructured":"Navin N, Kendall J, Troge J, Andrews P, Rodgers L, McIndoo J, et al. Tumour evolution inferred by single-cell sequencing. Nature. 2011;472(7341):90\u20134.","journal-title":"Nature"},{"issue":"1","key":"1684_CR85","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ccell.2023.11.010","volume":"42","author":"Y Sun","year":"2024","unstructured":"Sun Y, Wu P, Zhang Z, Wang Z, Zhou K, Song M, et al. Integrated multi-omics profiling to dissect the spatiotemporal evolution of metastatic hepatocellular carcinoma. Cancer Cell. 2024;42(1):135-156.e17.","journal-title":"Cancer Cell"},{"issue":"4","key":"1684_CR86","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1172\/JCI96149","volume":"128","author":"I Ullah","year":"2018","unstructured":"Ullah I, Karthik GM, Alkodsi A, Kj\u00e4llquist U, St\u00e5lhammar G, L\u00f6vrot J, et al. Evolutionary history of metastatic breast cancer reveals minimal seeding from axillary lymph nodes. J Clin Invest. 2018;128(4):1355\u201370.","journal-title":"J Clin Invest"},{"issue":"7","key":"1684_CR87","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1038\/s41559-021-01456-6","volume":"5","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, Fu X, Lopez JI, Rowan A, Au L, Fendler A, et al. Selection of metastasis competent subclones in the tumour interior. Nat Ecol Evol. 2021;5(7):1033\u201345.","journal-title":"Nat Ecol Evol"},{"issue":"5","key":"1684_CR88","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/s41576-022-00553-x","volume":"24","author":"Z Seferbekova","year":"2023","unstructured":"Seferbekova Z, Lomakin A, Yates LR, Gerstung M. Spatial biology of cancer evolution. Nat Rev Genet. 2023;24(5):295\u2013313.","journal-title":"Nat Rev Genet"},{"issue":"6282","key":"1684_CR89","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1126\/science.aaf2784","volume":"352","author":"S Turajlic","year":"2016","unstructured":"Turajlic S, Swanton C. Metastasis as an evolutionary process. Science. 2016;352(6282):169\u201375.","journal-title":"Science"},{"issue":"1","key":"1684_CR90","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ccell.2019.12.004","volume":"37","author":"NJ Birkbak","year":"2020","unstructured":"Birkbak NJ, McGranahan N. Cancer genome evolutionary trajectories in metastasis. Cancer Cell. 2020;37(1):8\u201319.","journal-title":"Cancer Cell"},{"issue":"14","key":"1684_CR91","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1038\/s41388-023-02596-8","volume":"42","author":"ML Baek","year":"2023","unstructured":"Baek ML, Lee J, Pendleton KE, Berner MJ, Goff EB, Tan L, et al. Mitochondrial structure and function adaptation in residual triple negative breast cancer cells surviving chemotherapy treatment. Oncogene. 2023;42(14):1117\u201331.","journal-title":"Oncogene"},{"issue":"48","key":"1684_CR92","doi-asserted-by":"publisher","first-page":"eaav0936","DOI":"10.1126\/scitranslmed.aav0936","volume":"11","author":"GV Echeverria","year":"2019","unstructured":"Echeverria GV, Ge Z, Seth S, Zhang X, Jeter-Jones S, Zhou X, et al. Resistance to neoadjuvant chemotherapy in triple-negative breast cancer mediated by a reversible drug-tolerant state. Sci Transl Med. 2019;11(48):eaav0936. https:\/\/doi.org\/10.1126\/scitranslmed.aav0936.","journal-title":"Sci Transl Med"},{"issue":"3","key":"1684_CR93","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41556-020-0477-0","volume":"22","author":"RT Davis","year":"2020","unstructured":"Davis RT, Blake K, Ma D, Gabra MBI, Hernandez GA, Phung AT, et al. Transcriptional diversity and bioenergetic shift in human breast cancer metastasis revealed by single-cell RNA sequencing. Nat Cell Biol. 2020;22(3):310\u201320.","journal-title":"Nat Cell Biol"},{"issue":"7418","key":"1684_CR94","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11412","volume":"490","author":"Comprehensive molecular portraits of human breast tumours","year":"2012","unstructured":"Comprehensive molecular portraits of human breast tumours. Nature. 2012;490(7418):61\u201370.","journal-title":"Nature"},{"issue":"7605","key":"1684_CR95","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature17676","volume":"534","author":"S Nik-Zainal","year":"2016","unstructured":"Nik-Zainal S, Davies H, Staaf J, Ramakrishna M, Glodzik D, Zou X, et al. Landscape of somatic mutations in 560 breast cancer whole-genome sequences. Nature. 2016;534(7605):47\u201354.","journal-title":"Nature"},{"key":"1684_CR96","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan F, Reis-Filho JS. Pathogenesis of triple-negative breast cancer. Annu Rev Pathol. 2022;17:181\u2013204.","journal-title":"Annu Rev Pathol"},{"issue":"10","key":"1684_CR97","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1038\/ng.3641","volume":"48","author":"R Gao","year":"2016","unstructured":"Gao R, Davis A, McDonald TO, Sei E, Shi X, Wang Y, et al. Punctuated copy number evolution and clonal stasis in triple-negative breast cancer. Nat Genet. 2016;48(10):1119\u201330.","journal-title":"Nat Genet"},{"issue":"5","key":"1684_CR98","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/s41587-020-00795-2","volume":"39","author":"R Gao","year":"2021","unstructured":"Gao R, Bai S, Henderson YC, Lin Y, Schalck A, Yan Y. Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes. Nat Biotechnol. 2021;39(5):599\u2013608.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"1684_CR99","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1158\/0008-5472.CAN-24-1211","volume":"85","author":"L Kuett","year":"2025","unstructured":"Kuett L, Bollhagen A, Tietscher S, Sobottka B, Eling N, Varga Z, et al. Distant metastases of breast cancer resemble primary tumors in cancer cell composition but differ in immune cell phenotypes. Cancer Res. 2025;85(1):15\u201331.","journal-title":"Cancer Res"},{"key":"1684_CR100","doi-asserted-by":"crossref","unstructured":"Hong R, Wu P, Qiu Y, Dong S, Huang Y, Lee K, et al. Geospatial genetic evolution and phenotypic plasticity in triple-negative breast cancer. Datasets. GSA for Human. 2026. https:\/\/ngdc.cncb.ac.cn\/search\/specific?db=hra&q=HRA008673","DOI":"10.1186\/s13073-026-01684-0"},{"key":"1684_CR101","doi-asserted-by":"crossref","unstructured":"Zhang S, Chen X, Jin E, Wang A, Chen T, Zhang X, et al. The GSA Family in 2025: A Broadened Sharing Platform for Multi-Omics and Multimodal Data. Genomics Proteomics Bioinformatics. 2025.","DOI":"10.1101\/2025.03.31.646270"},{"issue":"D1","key":"1684_CR102","doi-asserted-by":"publisher","first-page":"D30","DOI":"10.1093\/nar\/gkae978","volume":"53","author":"CNCB-NGDC Members and Partners","year":"2025","unstructured":"CNCB-NGDC Members and Partners. Database resources of the National Genomics Data Center, China National Center for Bioinformation in 2025. Nucleic Acids Res. 2025;53(D1):D30-d44.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1684_CR103","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2(5):401\u20134.","journal-title":"Cancer Discov"},{"key":"1684_CR104","doi-asserted-by":"crossref","unstructured":"Hong R, Wu P, Qiu Y, Dong S, Huang Y, Lee K, et al. Geospatial genetic evolution and phenotypic plasticity in triple-negative breast cancer. Github. 2026. https:\/\/github.com\/WuPin-bio\/TNBC-code","DOI":"10.1186\/s13073-026-01684-0"}],"container-title":["Genome Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13073-026-01684-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13073-026-01684-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T05:01:31Z","timestamp":1786683691000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13073-026-01684-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":104,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1684"],"URL":"https:\/\/doi.org\/10.1186\/s13073-026-01684-0","relation":{},"ISSN":["1756-994X"],"issn-type":[{"value":"1756-994X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Research and Ethics Committee of Sun Yat-sen University Cancer Center (SYSUCC) (B2017-087-Y02). All experiments involving human participants were conducted in accordance with the committee\u2019s guidelines and the principles of the Declaration of Helsinki. Informed consent was obtained from all participants.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"123"}}